Safety of a two-day ultra-rush immunotherapy in vespid allergic patients: focus on elevated serum tryptase.

Systemic mastocytosis (SM) is a disorder caused by the abnormal proliferation of mast cells (MCs) in one or more organs, leading to heterogeneous clinical presentations. SM patients are more at risk for hymenoptera-sting-induced anaphylaxis1 and in these patients indolent systemic mastocytosis (ISM) is the most frequent form of this disorder.

Source: Annals of Allergy, Asthma and Immunology - March 22, 2018 Category: Allergy & Immunology Authors: Maria Beatrice Bil ò, Alice Corsi, Stefano Agolini, Chiara Tontini, Leonardo Antonicelli Tags: Letter Source Type: research